To include your compound in the COVID-19 Resource Center, submit it here.

Unum plans NASDAQ IPO

Immuno-oncology company Unum Therapeutics Inc. (Cambridge, Mass.) filed on March 2 to raise up to $86.3 million in an IPO on NASDAQ underwritten

Read the full 230 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE